Table 2.
Parental strain | ethA/R KO | ethA/R KO complement ethA/R | pMV262-ethR | pMV306-ethR | ethA KO | |
---|---|---|---|---|---|---|
BCG | 10–20 | NA | 10–20 | ND | ND | ND |
CDC1551 | 2.5–5 | 40 | 2.5–5 | 20–40 | ND | 20–40 |
Erdman | 1.25–2.5 | 2.5–5 | 1.25–2.5 | 1.25–2.5 | 2.5–5 | 1.25–2.5 |
H37Rv | 1.25–2.5 | 2.5–5 | 1.25–2.5 | 2.5–5 | ND | 2.5–5 |
Bacterial suspensions corresponding to 1x, 2x, and 4x MIC50 were plated onto 7H11 agar plates. CFU were enumerated after 16 days incubation at 37°C and the CFU-based MIC90 range (in μM) was determined. pMV262-ethR was introduced into WT MTB strains. pMV306-ethR was introduced into ethA/R KO Erdman strain.
ND, not determined; DF, drug-free; NA, not available due to complete resistance to the drug.